PALATIN TECHNOLOGIES INC
8-A12B, 1999-12-13
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: CASELLA WASTE SYSTEMS INC, 10-Q, 1999-12-13
Next: STARBASE CORP, S-8, 1999-12-13





                     U.S. Securities and Exchange Commission
                             Washington, D.C. 20549

                                    FORM 8-A

                FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
                     PURSUANT TO SECTION 12(b) OR (g) OF THE
                         SECURITIES EXCHANGE ACT OF 1934


                           PALATIN TECHNOLOGIES, INC.
             (Exact name of registrant as specified in its charter)


             Delaware                                    95-4078884
(State of incorporation or organization)    (I.R.S. Employer Identification No.)


214 Carnegie Center, Suite 100
Princeton, New Jersey                                         08540
(Address of principal executive offices)                    (Zip Code)


If this Form relates to the registration of a class of debt securities and is
effective upon filing pursuant to General Instruction A.(c)(1), please check the
following box. [ ]

If this Form relates to the registration of a class of debt securities and is to
become effective simultaneously with the effectiveness of a concurrent
registration statement under the Securities Act of 1933 pursuant to General
Instruction A.(c)(2), please check the following box. [ ]

If this Form relates to the registration of a class of securities pursuant to
Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A.(c), check the following box.  [X]

If this Form relates to the registration of a class of securities pursuant to
Section 12(g) of the Exchange Act and is effective pursuant to General
Instruction A.(d), check the following box. [ ]

Securities Act registration statement file number to which this form relates:
not applicable

Securities to be registered pursuant to Section 12(b) of the Act:

         Title of each class                Name of each exchange on which
         to be so registered                each class is to be registered

Common stock, par value $.01 per share          American Stock Exchange

Securities to be registered pursuant to Section 12(g) of the Act:  not
applicable


<PAGE>


                 INFORMATION REQUIRED IN REGISTRATION STATEMENT

Item 1.  Description of Registrant's Securities to be Registered.

     COMMON STOCK. We are registering our common stock, $.01 par value per
share. We have authority to issue up to 75,000,000 shares of common stock.
Holders of common stock have one vote per share and no preemption rights.
Subject to the rights of holders of preferred stock, the holders of common stock
are entitled to receive pro rata any dividends or distributions which the board
of directors may declare on common stock, and any proceeds of liquidation or
dissolution.

     The power to issue preferred stock and the issuance of preferred stock
could delay or prevent a change of control of Palatin. Our board of directors
has the authority, without further stockholder approval, to issue shares of
preferred stock in one or more series and to fix the powers, preferences,
rights, privileges, limitations and restrictions of the preferred stock,
including:

     o    the number of shares constituting any series and the distinctive
          designation of the series,

     o    dividend rates,

     o    voting rights and the number of votes per share,

     o    conversion rights and the number of shares of common stock into which
          each share of preferred stock may be converted

     o    redemption rights and the amount payable per share,

     o    sinking fund provisions for the redemption of preferred stock, and

     o    liquidation or dissolution preferences.

     We have authority to issue up to 10,000,000 shares of preferred stock. The
board has previously designated three series of preferred stock totaling
1,682,875 shares. Shares of preferred stock from each series are currently
outstanding. Some terms of the outstanding preferred stock, described below,
could delay or prevent a change of control by diluting the voting power of
common stock, requiring the issuance of additional shares of common stock, or
requiring the consent of holders of preferred stock.

     SERIES A CONVERTIBLE PREFERRED STOCK. Series A stock is convertible at the
option of the holder, at any time, into the number of shares of common stock
determined by multiplying each share of Series A stock by $100 and dividing the
result by the current conversion price of $4.67. Each share of Series A stock is
currently convertible into approximately 21.4 shares of common stock and has
approximately 21.4 votes per share. The holders of Series A stock vote with
common stock as a single class unless separate class voting is required by law.
The number of common shares issuable on conversion of each share of Series A
stock, and the number of votes per share attributable to Series A stock, will
increase if we sell common stock, or securities

                                       2

<PAGE>


convertible into or exercisable for common stock, at a price per share less than
either the Series A conversion price or the market price of common stock.

     SERIES B CONVERTIBLE PREFERRED STOCK. Series B stock is convertible at the
option of the holder, at any time, into the number of shares of common stock
determined by multiplying each share of Series B stock by $100 and dividing the
result by the current conversion price of $3.52. Each share of Series B stock is
currently convertible into approximately 28.4 shares of common stock. The number
of common shares issuable on conversion of each share of Series B stock may
increase if we announce a transaction involving the purchase of 50% or more of
the common stock at a time when the market price of common stock is below the
Series B conversion price.

     The Series B stock does not vote unless required by law, except that
approval of holders of two-thirds of the outstanding Series B stock is required
to:

     o    alter the terms of the Series B stock,

     o    authorize any class of stock ranking prior to the Series B stock as to
          dividends, distributions or voting rights,

     o    amend the certificate of incorporation or bylaws so as to affect
          adversely any rights of holders of Series B stock,

     o    increase the authorized number of shares of Series B stock, or

     o    enter into any agreement with respect to the foregoing.


     SERIES C CONVERTIBLE PREFERRED STOCK. Each share of Series C stock is
convertible on or after August 15, 2004 into one share of common stock. The
stock may be converted earlier than August 15, 2004 upon a change in control in
Palatin. A change in control includes:

     o    the acquisition by a third party of more than 50% of the combined
          voting power of our stock,

     o    a change in the majority of our board of directors, or

     o    a sale of all or substantially all of our assets or lines of business.

The holders of Series C stock also have the right to acquire additional shares
of common stock if a dilutive event occurs. Dilutive events include the issuance
and sale of common stock and the issuance of common stock pursuant to a stock
split, dividend or recapitalization. The Series C stock does not vote, unless
required by law.

     FUTURE ISSUANCE OF PREFERRED STOCK. In addition to the preferred stock
outstanding, the board could designate and issue preferred stock with different
voting, conversion and other rights that could delay or prevent a change of
control.

                                       3

<PAGE>


Item 2.  Exhibits.

         None.



                                    SIGNATURE

     Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereunto duly authorized.


PALATIN TECHNOLOGIES, INC.


By: /s/ Stephen T. Wills
    -------------------------
    Stephen T. Wills
    Executive Vice President and Chief Financial Officer



Date:  December 10, 1999






                                       4




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission